United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
kytril 2mg tablets
atnahs pharma uk ltd - granisetron hydrochloride - oral tablet - 2mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
leustat 10mg/10ml solution for infusion vials
atnahs pharma uk ltd - cladribine - solution for infusion - 1mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bondronat 50mg tablets
atnahs pharma uk ltd - ibandronic sodium monohydrate - tablet - 50mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bondronat 6mg6ml concentrate for solution for infusion vials
atnahs pharma uk ltd - ibandronic sodium monohydrate - solution for infusion - 1mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bonviva 150mg tablets
atnahs pharma uk ltd - ibandronic sodium monohydrate - tablet - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bonviva 3mg3ml solution for injection pre-filled syringes
atnahs pharma uk ltd - ibandronic sodium monohydrate - solution for injection - 1mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bondronat 2mg2ml concentrate for solution for infusion vials
atnahs pharma uk ltd - ibandronic sodium monohydrate - solution for infusion - 1mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
olsalazine 500mg tablets
atnahs pharma uk ltd - olsalazine sodium - oral tablet - 500mg
European Union -
English -
EMA (European Medicines Agency)
ghryvelin (previously macimorelin aeterna zentaris)
atnahs pharma netherlands b.v. - macimorelin acetate - diagnostic techniques, endocrine - macimorelin - this medicinal product is for diagnostic use only. ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.
Australia -
English -
Department of Health (Therapeutic Goods Administration)
bondronat ibandronic acid 6mg/6ml (as sodium) injection vial
atnahs pharma australia pty ltd - ibandronate sodium, quantity: 1.125 mg/ml (equivalent: ibandronic acid, qty 1 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - indicated for the treatment of: tumor-induced hypercalcaemia with or without metastases. metastatic bone disease in patients with breast cancer.